Key Market Indicators
Belgian antirheumatic medicine sales are expected to reach $90 million by 2026. In 2021, the market was valued at $102 million. This represents a projected decrease of 2.3% each year since 2007. Belgium was the 6th largest market in 2021. Italy overtook the country with sales of $103 million. Germany, Spain, and Canada were the next three biggest markets, in that order.
